Ghorashian, S; Veliça, P; Chua, I; McNicol, AM; Carpenter, B; Holler, A; Nicholson, E; ... Stauss, HJ; + view all Ghorashian, S; Veliça, P; Chua, I; McNicol, AM; Carpenter, B; Holler, A; Nicholson, E; Ahmadi, M; Zech, M; Xue, SA; Uckert, W; Morris, E; Chakraverty, R; Stauss, HJ; - view fewer (2015) CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor. Journal of Immunology , 194 (3) 1080 - 1089. 10.4049/jimmunol.1401703.

	Text CD8 T Cell Tolerance to a Tumor-Associated Self-Antigen.pdf Available under License : See the attached licence file. Download (1MB)
Preview	Text Ghorasian_CD8_cell_tolerance_to_a_tumour.pdf - Accepted Version Available under License : See the attached licence file. Download (1MB) | Preview

Abstract

Ag receptors used for cancer immunotherapy are often directed against tumor-associated Ags also expressed in normal tissues. Targeting of such Ags can result in unwanted autoimmune attack of normal tissues or induction of tolerance in therapeutic T cells. We used a murine model to study the phenotype and function of T cells redirected against the murine double minute protein 2 (MDM2), a tumor-associated Ag that shows low expression in many normal tissues. Transfer of MDM2-TCR-engineered T cells into bone marrow chimeric mice revealed that Ag recognition in hematopoietic tissues maintained T cell function, whereas presentation of MDM2 in nonhematopoietic tissues caused reduced effector function. TCR-engineered CD8(+) T cells underwent rapid turnover, downmodulated CD8 expression, and lost cytotoxic function. We found that MDM2-TCR-engineered CD4(+) T cells provided help and restored cytotoxic function of CD8(+) T cells bearing the same TCR. Although the introduction of the CD8 coreceptor enhanced the ability of CD4(+) T cells to recognize MDM2 in vitro, the improved self-antigen recognition abolished their ability to provide helper function in vivo. The data indicate that the same class I-restricted TCR responsible for Ag recognition and tolerance induction in CD8(+) T cells can, in the absence of the CD8 coreceptor, elicit CD4 T cell help and partially reverse tolerance. Thus MHC class I-restricted CD4(+) T cells may enhance the efficacy of therapeutic TCR-engineered CD8(+) T cells and can be readily generated with the same TCR.

Download activity - last month

Export as CSVJSONXML

Download activity - last 12 months

Export as JSONCSVXML

Downloads by country - last 12 months

Export as XMLCSVJSON

Archive Staff Only

View Item